current international priorities in health research opportunities for epidemiology
Download
Skip this Video
Download Presentation
Current International Priorities in Health Research Opportunities for Epidemiology

Loading in 2 Seconds...

play fullscreen
1 / 38

Current International Priorities in Health Research Opportunities for Epidemiology - PowerPoint PPT Presentation


  • 111 Views
  • Uploaded on

Current International Priorities in Health Research Opportunities for Epidemiology. Henry Völzke. The Risk Transition. WHO 2009. The Obesity Map, 2008. www.hsph.harvard.edu. Finucane et al.; Lancet 2011. WHO 2009. WHO 2009. Known Risk Factors for MI. Yusuf et al., Lancet 2007.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Current International Priorities in Health Research Opportunities for Epidemiology' - brittany-lancaster


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
current international priorities in health research opportunities for epidemiology

Current International Priorities in Health ResearchOpportunities for Epidemiology

Henry Völzke

the obesity map 2008
The Obesity Map, 2008

www.hsph.harvard.edu

known risk factors for mi
Known Risk Factors for MI

Yusuf et al., Lancet 2007

risk factors for peptic ulcer
Risk Factors for Peptic Ulcer
  • Stress
  • Alcohol
  • Smoking
  • Diet
  • Family History

wikipedia.org

slide10

Society

Science

Epidemiology

  • Disparities
  • Health care allocation
  • Preventive programs
  • Prognosis
  • Risk factors
  • Predictors
  • Interactions
  • Subgroups
slide13

RESEARCH NETWORK COMMUNITY MEDICINE

Community Medicine

Epidemiology

Clinical Chemistry

Radiology

Molecular Medicine

SHIP

SNiP

Interventions

Microbiology

Psychiatry

Cardiology

Pneumology

Dentistry

Dermatology

Economics

Neurology

Gastroenterology

Endocrinology

objectives
Objectives

Prevalence and incidence of common risk factors and diseases

Associations and interactions among common risk factors, subclinical disorders and diseases

slide15

Rügen

Stralsund

Nordvorpommern

Greifswald

Use-

Ostvorpommern

dom

Schleswig-

Holstein

Mecklenburg

-

Vorpommern

Hamburg

Brandenburg

Niedersachsen

Berlin

Sachsen-

Anhalt

N= 4308

20-79 years

slide16

SHIP-0

Baseline

SHIP-1

5y Follow-up

SHIP-2

10y Follow-up

n= 4308 (68.8%)

n= 3300 (84.5%)

n= 2333

(63.5%)

SHIP-TREND

Baseline

n= 4422

(50.3%)

1997-2001

2002-2006

2008-2012

slide20

GWA Uric Acid

Metabolomics

Doering, et al. Nat Genetics 2008

missing teeth and mortality
Missing Teeth and Mortality

Polzer et al., Int J Cardiol 2012

publications
Publications

1-2 publications/ week, mean impact factor ~7

  • Cardiovascular Disease(JAMA, Lancet, Nat Genetics, Circulation, JACC, Eur Heart J, ATVB, Hypertension, Nat Rev Cardiol)
  • Metabolic Syndrome(Nature, Science, Nat Genetics, Diabetes, Diab Care, JCEM)
  • Gastroenterology(Nat Genetics, Gastroenterology, Gut, Hepatology, Am J Gastroenterol)
  • Thyroidology(JAMA, Arch Intern Med, Am J Hum Genetics, JCEM, Thyroid)
  • Psychiatry(JAMA, Nat Genetics, Am J Psychiatry, Biol Psychiatry, Mol Psychiatry)
  • Dentistry(Diab Care,Dent Res, J Clin Periodontol, Thromb Haemost, J Hypertens)
  • Haematology & Oncology(Nat Genetics, Blood, Am J Hum Genetics)
  • Neurology(Lancet, Nat Genetics, Arch Intern Med, Stroke)
  • Pneumology(Nat Genetics, Eur Respiratory J, Chest)
  • Nephrology(Nat Genetics, J Am Soc Nephrol, Kidney Int)
  • Epidemiology(Science, Am J Epidemiol,Int J Epidemiol, J Clin Epidemiol, Eur J Epidemiol)
publications1
Publications

1-2 publications/ week, mean impact factor 7

  • Cardiovascular Disease(JAMA, Lancet, Nat Genetics, Circulation, JACC, Eur Heart J, ATVB, Hypertension, Nat Rev Cardiol)
  • Metabolic Syndrome(Nature, Science, Nat Genetics, Diabetes, Diab Care, JCEM)
  • Gastroenterology(JAMA, Nat Genetics, Gastroenterology, Gut, Hepatology, Am J Gastroenterol)
  • Thyroidology(JAMA, Arch Intern Med, Am J Hum Genetics, JCEM, Thyroid)
  • Psychiatry(JAMA, Nat Genetics, Am J Psychiatry, Biol Psychiatry, Mol Psychiatry)
  • Dentistry(Diab Care,Dent Res, J Clin Periodontol, Thromb Haemost, J Hypertens)
  • Haematology & Oncology(Nat Genetics, Am J Hum Genetics)
  • Neurology(Lancet, Arch Intern Med, Stroke)
  • Pneumology(Nat Genetics, Eur Respiratory J, Chest)
  • Nephrology(Nat Genetics, J Am Soc Nephrol, Kidney Int)
  • Epidemiology(Int J Epidemiol, Am J Epidemiol, J Clin Epidemiol, Eur J Epidemiol)
slide27

Methods of Quality Management

  • Standard Operating Procedures for each examination method
  • Training of potential observers in hospitals and the SHIP examination center
  • Reader certification (2 x 25 images)
    • Intra- and Inter-Reader-Variability
  • Observer certification (2 x 12 volunteers before and 2 x 6 volunteers semiannually during the study)
    • Intra- and Inter-Observer-Variability
  • Calibration and re-certification
  • Paper-free data documentation
  • Semiannual quality reports to the Data Safety & Monitoring Committee
slide28

Tasks

Data Dictionary

Proband Management

Training Certification

Data Collection

Infrastructure (Devices, Computers, Facilities)

Communication Structures

Quality Monitoring

Data Clean-up

Data Transfer

slide31

Recruitment of patient cohorts

(in accordance with methods and quality standards of SHIP)

Comparison to

SHIP cohorts

Comparison to

SHIP cohorts

Cardiovascular

Heart failure

(systolic & diastolic)

FOLLOW-UP

Subclinical

and overt phenotypes

Morbidity

Mortality

BASELINE

Comprehensive,

standardized phenotyping

Subclinical and overt parameters

Biobanking

OMICs

Metabolism

Metabolic syndrome

& co-morbidities

Renal

Renal insufficiency

Cerebrovascular

Stroke / TIA

slide32

The Vision

International

To build up an international consortium to collect multi-national population data

Collaborative use of SHIP instruments for standardization and quality assurance

To achieve best possible comparability of phenotypic data

slide36

Potential Bias in Global Epi Research

Even high-quality epidemiological studies usually take less care on external validity!

slide37

International

Santiago de Chile

Pomerode

ad